Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 39 publications
Hodgkin Lymphoma, Version 1.2026, NCCN Clinical Practice Guidelines In Oncology.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: February 11, 2026
A Phase 1 Trial of Duvelisib and Oral Azacitidine in Relapsed/Refractory T-Cell Lymphoma.
Journal: Hematological oncology
Published: November 03, 2025
Autologous Hematopoietic Cell Transplantation Consolidation for First Response is Associated With Longer Survival Among Patients With Nodal Peripheral T Cell Lymphoma.
Journal: Transplantation and cellular therapy
Published: March 15, 2024
Long-term follow up of the combination of ofatumumab, high-dose methylprednisolone, and lenalidomide for untreated chronic lymphocytic leukemia with biomarker analysis.
Journal: Clinical lymphoma, myeloma & leukemia
Published: November 28, 2023
Outcomes of marginal zone lymphoma treated with ibrutinib in the first-line setting in the United States: a real-world analysis.
Journal: Blood advances
Published: September 17, 2023
B-cell maturation antigen expression and clinical features of plasmablastic lymphoma.
Journal: EJHaem
Published: August 19, 2023
Toxicity of a Modified PEG-Asparaginase-Based SMILE Regimen Is Comparable to L-Asparaginase-Based SMILE in a Non-Asian Population.
Journal: Clinical lymphoma, myeloma & leukemia
Published: January 22, 2023
Frontline treatment approaches in TP53-aberrant mantle cell lymphoma.
Journal: Leukemia & lymphoma
Published: October 27, 2022
Postibrutinib relapse outcomes for patients with marginal zone lymphoma.
Journal: Blood advances
Published: July 25, 2022
Last Updated: 09/26/2026